The chemical activators in this category would likely exert their effect through a direct interaction with the STAMBPL1 protein, altering its conformation to a more active state or stabilizing the active site configuration. Such compounds could bind to allosteric sites on the enzyme, leading to a conformational change that results in enhanced catalytic efficiency. They might also prevent the binding of endogenous inhibitors or protect STAMBPL1 from proteasomal degradation. The design of these molecules would require a detailed understanding of the enzyme's structure to identify potential binding sites and to develop compounds that are capable of engaging with the enzyme in a manner that promotes its deubiquitinating activity.
Research into the development of STAMBPL1 activators would be driven by an interest in understanding the fundamental aspects of protein regulation by ubiquitination. Since ubiquitin signaling is a post-translational modification that affects a wide array of cellular processes, the ability to modulate this signaling through the targeted activation of STAMBPL1 could have significant implications for the study of cell signaling and protein turnover. A comprehensive understanding of how STAMBPL1 activators interact with their target and influence its activity would not only deepen our knowledge of ubiquitin-mediated signaling pathways but also contribute to the broader field of enzymology and protein regulation within the cellular environment.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent protein kinase C (PKC) activator. PKC is involved in numerous cellular signaling pathways. PMA's activation of PKC can enhance the ubiquitination process, where STAMBPL1 plays a crucial role as a deubiquitinating enzyme. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A. By inhibiting these phosphatases, it indirectly enhances the phosphorylation state of proteins, thereby potentially influencing the ubiquitination and deubiquitination processes where STAMBPL1 functions. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Epoxomicin is a potent, selective, and irreversible proteasome inhibitor. It inhibits the degradation of ubiquitinated proteins, thereby indirectly influencing STAMBPL1's function in the deubiquitination process. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is a potent inhibitor of protein phosphatase 1 and 2A. Similar to okadaic acid, it might indirectly affect STAMBPL1's function by enhancing protein phosphorylation and subsequently influencing ubiquitination. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a potent inhibitor of PI3K, which is involved in numerous cellular signaling pathways that can influence ubiquitination and deubiquitination, thereby indirectly affecting the function of STAMBPL1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAPK. p38 MAPK is involved in stress response pathways that can influence protein ubiquitination and deubiquitination, hence the function of STAMBPL1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of MEK. By inhibiting MEK, it affects the ERK pathway and might indirectly influence STAMBPL1’s function in deubiquitination. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a selective inhibitor of JNK, which is involved in stress and immune response pathways that can influence ubiquitination and deubiquitination, thereby affecting the function of STAMBPL1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an inhibitor of mTOR, a major regulator of cell growth and proliferation. mTOR influences various cellular processes, including protein ubiquitination, where STAMBPL1 functions. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of PI3K, influencing cellular pathways that may indirectly affect STAMBPL1's function in the ubiquitination process. | ||||||